TotalMarketCap

Agios Pharmaceuticals

AGIONasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$1.700 B

$28.48 -9.26%

Close of 6 Nov 2026

As of 6 Nov 2026, Agios Pharmaceuticals (AGIO) has a market capitalization of $1.70B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$54.0M

#2688 by revenue

Earnings

-$413.0M

Loss-making

Shares outstanding

59,809,651

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #102Stoke TherapeuticsSTOK$1.70B
  2. #103Zenas BioPharmaZBIO$1.70B
  3. #104Agios PharmaceuticalsAGIO$1.70B
  4. #105Generate BiomedicinesGENB$1.64B
  5. #106Nurix TherapeuticsNRIX$1.63B

What if Agios Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$472,964.55

Per share 16,610× higher

Bitcoin $1.53T

$25,591.29

Per share 899× higher

Apple $5.02T

$84,013.81

Per share 2,950× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Agios Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.